Cell Expansion

Vycellix Platform: VY-M
Enabling Accelerated Large-scale Cell Expansion with Significant Cost/Speed Efficiencies

VY-M confers significant cell manufacturing benefits as an ex vivo cell manufacturing reagent which optimizes proliferation of T cells, NK cells and other cells with conserved functional capacity (autologous or allogeneic). VY-M is readily adaptable to multiple protocols and is highly-differentiated from other expansion platforms in its ability to decrease non-dividing lag time, resulting in significantly shorter ‘vein-to-vein’ delivery-time to patients at lower production costs.